CL
LLY icon

Choreo LLC’s Eli Lilly LLY Stock Holding History

Choreo LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27M Buy
29,407
+303
+1% +$307K 0.33% 55
2025
Q4 		$31.4M Sell
29,104
-1,084
-4% -$1.04M 0.4% 45
2025
Q3 		$23M Sell
30,188
-366
-1% -$272K 0.3% 61
2025
Q2 		$23.8M Buy
30,554
+1,598
+6% +$1.24M 0.33% 57
2025
Q1 		$23.9M Buy
28,956
+405
+1% +$337K 0.37% 55
2024
Q4 		$22.1M Sell
28,551
-1,935
-6% -$1.6M 0.32% 61
2024
Q3 		$27M Buy
30,486
+2,553
+9% +$2.3M 0.4% 55
2024
Q2 		$25.5M Buy
27,933
+19,704
+239% +$15.8M 0.43% 48
2024
Q1 		$6.4M Sell
8,229
-414
-5% -$295K 0.16% 89
2023
Q4 		$5.04M Buy
8,643
+2,257
+35% +$1.32M 0.14% 102
2023
Q3 		$3.43M Sell
6,386
-48
-0.7% -$24.7K 0.12% 98
2023
Q2 		$3.02M Buy
6,434
+123
+2% +$51.6K 0.1% 110
2023
Q1 		$2.17M Buy
6,311
+4,433
+236% +$1.5M 0.08% 145
2022
Q4 		$684K Buy
1,878
+684
+57% +$243K 0.03% 125
2022
Q3 		$386K Sell
1,194
-2
-0.2% -$634 0.02% 147
2022
Q2 		$388K Sell
1,196
-317
-21% -$95.2K 0.02% 146
2022
Q1 		$433K Buy
1,513
+365
+32% +$93.9K 0.02% 152
2021
Q4 		$317K Buy
1,148
+165
+17% +$41.8K 0.02% 179
2021
Q3 		$227K Sell
983
-27
-3% -$6.66K 0.01% 195
2021
Q2 		$232K Buy
+1,010
New +$203K 0.01% 197
2020
Q3 		– Sell
-1,368
Closed -$225K – 188
2020
Q2 		$225K Sell
1,368
-428
-24% -$65.7K 0.02% 168
2020
Q1 		$249K Sell
1,796
-238
-12% -$32.7K 0.03% 152
2019
Q4 		$267K Buy
+2,034
New +$236K 0.03% 169
2019
Q2 		– Sell
-1,604
Closed -$208K – 200
2019
Q1 		$208K Sell
1,604
-1,583
-50% -$192K 0.03% 191
2018
Q4 		$369K Sell
3,187
-477
-13% -$53.3K 0.05% 125
2018
Q3 		$393K Buy
3,664
+91
+3% +$9.1K 0.05% 144
2018
Q2 		$305K Sell
3,573
-1,245
-26% -$102K 0.04% 183
2018
Q1 		$373K Sell
4,818
-173
-3% -$13.9K 0.04% 185
2017
Q4 		$422K Sell
4,991
-967
-16% -$82.3K 0.05% 177
2017
Q3 		$510K Sell
5,958
-2,513
-30% -$206K 0.07% 148
2017
Q2 		$697K Sell
8,471
-244
-3% -$19.9K 0.1% 110
2017
Q1 		$733K Buy
8,715
+3,195
+58% +$256K 0.11% 108
2016
Q4 		$406K Sell
5,520
-1,146
-17% -$85.3K 0.06% 158
2016
Q3 		$535K Sell
6,666
-42
-0.6% -$3.36K 0.09% 114
2016
Q2 		$528K Sell
6,708
-17
-0.3% -$1.28K 0.1% 104
2016
Q1 		$484K Sell
6,725
-195
-3% -$14.8K 0.1% 101
2015
Q4 		$583K Sell
6,920
-303
-4% -$25.1K 0.14% 80
2015
Q3 		$604K Buy
7,223
+831
+13% +$70.2K 0.16% 68
2015
Q2 		$534K Buy
6,392
+28
+0.4% +$2.13K 0.13% 82
2015
Q1 		$462K Buy
6,364
+409
+7% +$29.1K 0.12% 89
2014
Q4 		$411K Sell
5,955
-24
-0.4% -$1.62K 0.11% 92
2014
Q3 		$388K Buy
5,979
+9
+0.2% +$570 0.11% 88
2014
Q2 		$371K Sell
5,970
-222
-4% -$13.2K 0.1% 94
2014
Q1 		$364K Buy
+6,192
New +$346K 0.11% 94

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Choreo LLC's LLY Position: Q1 2026 in Review

Choreo LLC increased its Eli Lilly (LLY) stake by 1% in Q1 2026, buying an estimated $307K and bringing the position to 29,407 shares worth $27M. The position accounts for 0.33% of the portfolio, ranked #55.

Choreo LLC first reported a position in LLY in Q1 2014 and has held it in 44 quarters since. The position peaked at $31.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Choreo LLC held 29,407 shares of Eli Lilly worth $27M as of Q1 2026.
  • Choreo LLC bought 303 Eli Lilly shares in Q1 2026, an estimated $307K.
  • Eli Lilly made up 0.33% of Choreo LLC's portfolio in Q1 2026, its #55 holding.
  • Choreo LLC first reported a position in Eli Lilly in Q1 2014 and has held it in 44 quarters since.
  • Choreo LLC's Eli Lilly position peaked at $31.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.